Showing results (1551-1560 of 1,570) with videos related to
Sort By:
Pageof 157
The Journal of Cell Biology|November 23, 2021
LUBAC regulates ciliogenesis by promoting CP110 removal from the mother centrioleXiao-Lin Shen, Jin-Feng Yuan, Xuan-He Qin, et al.Transplantation and Cellular Therapy|November 19, 2022
Hematopoietic Stem Cell Transplantation Activity in China 2020-2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry GroupLan-Ping Xu, Dao-Pei Lu, De-Pei Wu, et al.American Journal of Human Genetics|November 11, 2008
Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosisTie-Lin Yang, Xiang-Ding Chen, Yan Guo, et al.Circulation. Genomic and Precision Medicine|February 10, 2021
Cadherin 2-Related Arrhythmogenic Cardiomyopathy: Prevalence and Clinical FeaturesAlice Ghidoni, Perry M Elliott, Petros Syrris, et al.Thoracic Cancer|September 19, 2017
Long-term results of a randomized, double-blind, and placebo-controlled phase III trial: Endostar (rh-endostatin) versus placebo in combination with vinorelbine and cisplatin in advanced non-small cell lung cancerYan Sun, Jin Wan Wang, Yong Yu Liu, et al.Chinese Medical Journal|July 31, 2018
Three-year Follow-up on the Safety and Effectiveness of Rituximab Plus Chemotherapy as First-Line Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in Real-World Clinical Settings in China: A Prospective, Multicenter, Noninterventional StudyJian-Qiu Wu, Yong-Ping Song, Li-Ping Su, et al.Journal of Cancer Research and Clinical Oncology|April 11, 2024
Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia: a randomized phase 3 trial with 5-year outcomesJie Tian, Yong-Ping Song, Gao-Chong Zhang, et al.Leukemia|October 20, 2020
Donor-derived CD19 CAR-T cell therapy of relapse of CD19-positive B-ALL post allotransplantCheng Zhang, Xiao-Qi Wang, Rong-Li Zhang, et al.Journal of Evidence-Based Medicine|September 19, 2022
Clinical guideline for the diagnosis and treatment of cutaneous warts (2022)Peiyao Zhu, Rui-Qun Qi, Yang Yang, et al.Blood Advances|April 20, 2023
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm studyLi-Juan Deng, Ke-Shu Zhou, Li-Hong Liu, et al.Pageof 157